Caplin Point Laboratories Limited has informed the Exchange regarding Cessation of Dr. C K Gariyali as Non- Executive Independent Director of the company w.e.f. March 03, 2026.
CAPLIPOINT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. C K Gariyali (DIN: 08711546) has ceased to be an Independent Director of Caplin Point Laboratories with effect from the close of business hours on March 3, 2026. The company stated that this cessation is due to Dr. Gariyali completing her maximum permitted tenure as an Independent Director under applicable rules. She had served two consecutive terms on the board. The intimation has been made under SEBI LODR Regulation 30, and the required disclosure details have been filed. No replacement appointment details were disclosed in this filing.
This is a routine, regulatory-driven board change with no governance concerns flagged. It is unlikely to have any material impact on the company's operations or stock price, as the departure is due to completion of the legally permitted tenure rather than any performance or governance issue.